Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

<div>Management algorithm of initially unresectable stage IIIC and IV ovarian cancer patients. ASC: Adjuvant systemic chemotherapy, CRS/HIPEC: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, ECOG: Eastern Cooperative Oncology Group Performance Status, NACT: Neoadjuvant systemic chemotherapy, SIII: Stage IIIC, SIV: Stage IVA/B.</div>

International Journal of Surgical Oncology

fig1

Figure 1

Figure 1: Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) 

Figure 1 | Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) 